PT901633E - Rastreio de agentes para tratamento da doenca de alzheimer - Google Patents

Rastreio de agentes para tratamento da doenca de alzheimer

Info

Publication number
PT901633E
PT901633E PT97923188T PT97923188T PT901633E PT 901633 E PT901633 E PT 901633E PT 97923188 T PT97923188 T PT 97923188T PT 97923188 T PT97923188 T PT 97923188T PT 901633 E PT901633 E PT 901633E
Authority
PT
Portugal
Prior art keywords
agent
alzheimer
disease
filaments
treatment
Prior art date
Application number
PT97923188T
Other languages
English (en)
Inventor
Michel Goedert
Ross Jakes
Maria Grazia Spillantini
Masato Hasegawa
Michael John Smith
Richard Anthony Crowther
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of PT901633E publication Critical patent/PT901633E/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • Y10T436/144444Glucose

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT97923188T 1996-05-23 1997-05-20 Rastreio de agentes para tratamento da doenca de alzheimer PT901633E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9610829.5A GB9610829D0 (en) 1996-05-23 1996-05-23 Screening of agents for treatment of azlheimers disease

Publications (1)

Publication Number Publication Date
PT901633E true PT901633E (pt) 2003-07-31

Family

ID=10794213

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97923188T PT901633E (pt) 1996-05-23 1997-05-20 Rastreio de agentes para tratamento da doenca de alzheimer

Country Status (10)

Country Link
US (1) US6245575B1 (pt)
EP (1) EP0901633B1 (pt)
JP (1) JP2001503509A (pt)
AT (1) ATE235058T1 (pt)
DE (1) DE69719978T2 (pt)
DK (1) DK0901633T3 (pt)
ES (1) ES2194198T3 (pt)
GB (1) GB9610829D0 (pt)
PT (1) PT901633E (pt)
WO (1) WO1997044669A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020197737A1 (en) * 1996-12-13 2002-12-26 Eckhard Mandelkow Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease
WO2004041779A2 (en) 2002-11-01 2004-05-21 Proteotech, Inc. Amyloid plaque formation by glycosaminoglycans
FR2888937B1 (fr) * 2005-07-21 2012-10-26 Biomerieux Sa Procede de detection des fcpa utilisant un agent d'agregation des fcpa et un agent de capture des agregats formes
KR101095630B1 (ko) * 2009-06-17 2011-12-19 주식회사 이노파마스크린 베타 아밀로이드 펩타이드와 vegf의 상호작용을 억제하는 물질을 탐색 방법 및 그에 의해서 탐색된 저해제
JP2013032295A (ja) * 2009-12-04 2013-02-14 Kaneka Corp タウ蛋白の吸着材および吸着除去システム
KR20190127860A (ko) * 2017-03-28 2019-11-13 얀센 백신스 앤드 프리벤션 비.브이. 타우 단백질 응집 조절 화합물의 검출 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164295A (en) * 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
US5705401A (en) 1991-11-12 1998-01-06 The University Of Melbourne Method of assaying for alzheimer's disease
ATE398176T1 (de) 1991-12-06 2008-07-15 Max Planck Gesellschaft Phosphorylierungsepitope aus dem tau-protein zur diagnose und behandlung der alzheimer-krankheit
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
US5643562A (en) * 1993-03-29 1997-07-01 Queen's University Of Kingston Method for treating amyloidosis

Also Published As

Publication number Publication date
ATE235058T1 (de) 2003-04-15
ES2194198T3 (es) 2003-11-16
DK0901633T3 (da) 2003-06-16
EP0901633B1 (en) 2003-03-19
DE69719978T2 (de) 2003-12-18
DE69719978D1 (de) 2003-04-24
JP2001503509A (ja) 2001-03-13
GB9610829D0 (en) 1996-07-31
WO1997044669A1 (en) 1997-11-27
US6245575B1 (en) 2001-06-12
EP0901633A1 (en) 1999-03-17

Similar Documents

Publication Publication Date Title
EE200100645A (et) Amüloidogeense haiguse preventsioon ja ravi
EP0792156A4 (en) METHOD FOR PREVENTING OR TREATING VASCULAR HEMORRAGIES AND ALZHEIMERIC DISEASE
DE69526120D1 (de) Verwendung von nebivolol als anti-atherogenisches mittel
TW264480B (pt)
DE59611341D1 (de) Verwendung von saccharid-konjugaten
BR9909382A (pt) Anticorpo humanizado contra o fator tissular humano (tf) e processo de produção de anticorpo humanizado
DE60027762D1 (de) Diagnose und behandlung von arthritischen erkrankungen
NO962130L (no) Synergistisk behandling av Parkinsons sykdom
MX9606386A (es) Agentes que afectan la hemostasis trombotica.
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
MXPA03010843A (es) Uso de derivados con azetidinona en el tratamiento de enfermedad de alzheimer.
DE69626610D1 (de) Produkt enthaltend Rapamycin oder ausgewählte Derivate und einen NMDA- oder AMPA-Antagonisten zur Verwendung für die Behandlung von Epilepsie oder Morbus Huntington, und die Verwendung von Rapamycin oder von ausgewählten Derivaten für die Herstellung eines Medikaments für die Behandlung von Epilepsie oder Morbus Huntington.
KR920700667A (ko) 세포간 점착분자 및 그의 결합리간드의 천식치료에의 이용
PT901633E (pt) Rastreio de agentes para tratamento da doenca de alzheimer
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
NO984651D0 (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
NO20012849L (no) Ny terapeutisk anvendelse for hepariner med lav molekylvekt
AU5757598A (en) Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease
YUWILER et al. Drs. Yuwiler and Ritvo Reply
PT1133297E (pt) Nova aplicacao terapeutica da 1,6-dimetil-8beta-hidroximetil-10alfa-metoxiergolina